New research into the speed of diagnosis of hypertrophic cardiomyopathy in the United States is providing new insight into trends in disease management. Presented at the American Heart Association Scientific Session 2023, results of the analysis, which leveraged Medicare claims data from 2016-2020, detail disparities in diagnosis of older patients with hypertrophic cardiomyopathy, with evidence of race- and income-based disparities. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more